Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
233 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Currently Recruiting (1)
  • Closed (2)

Medical Condition

  • Show all (105)
  • (-) Addiction (1)
    • Alcohol (1)
  • Blood Disorders (1)
  • Diabetes (4)
  • Endocrine & Metabolic Disease (3)
  • Eye (1)
  • Gastrointestinal and Digestive Diseases (1)
  • Healthy Volunteers (3)
  • Heart Disease (11)
  • Infectious Disease (4)
  • Kidney Disease (1)
  • Liver Disease (60)
    • Cirrhosis of the Liver (8)
    • Hepatic Encephalopathy (2)
    • Hepatitis (10)
    • (-) Liver Failure (2)
    • MASH (formerly NASH) (4)
  • Lung Disease (1)
  • Nutrition (1)
  • Obesity (3)
  • Obstetrics & Gynecology (1)
  • Pediatrics (1)
  • Transplant (8)
Displaying 1 - 3 of 3

TReatment for ImmUne Mediated PathopHysiology (TRIUMPH)

Condition: Liver Disease / Liver Failure
Investigator: Steven Lobritto, MD
Status: Currently Recruiting
TReatment for ImmUne Mediated PathopHysiology (TRIUMPH) is a multi-center, three-arm clinical trial of immunosuppressive therapy for children with acute liver failure. This is a double-blind study, so the study doctors and participants will not know to which arm the participants are assigned. The study will determine if…
Read More

Study to Evaluate the Efficacy & Safety of Treatment with Efimosfermin Alfa in Adult Participants with Alcohol-related Liver Disease (ALD)

Condition: Addiction / Alcohol
Investigator: Gene Im, MD, FAASLD
Status: Closed
Researchers at Columbia University Irving Medical Center are investigating whether the investigational medication efimosfermin is safe and effective in improving outcomes for adults with Alcohol-related Liver Disease (ALD). ALD refers to liver damage caused by heavy…
Read More

Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)

Condition: Liver Disease / Liver Failure
Investigator: Elizabeth Verna, MD
Status: Closed
The purpose of this research study is to determine if an investigational drug, VS-01, will help in the treatment of acute-on-chronic liver failure (ACLF) compared to supportive care (standard of therapy). ACLF is a potentially life-threatening condition characterized by a group of signs that occur together (syndrome) in…
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science